1031.9500 -4.95 (-0.48%)
NSE Sep 16, 2025 13:44 PM
Volume: 286.2K
 

1031.95
-0.48%
Karvy
Margins decline due to lower domestic revenues and price impact on key products: Cadila's revenues increased by 15.3% on a YoY basis to Rs 37.3 bn (our estimate of Rs 38.1 bn) during the quarter.
Zydus Lifesciences Ltd. is trading above all available SMAs
More from Zydus Lifesciences Ltd.
Recommended